Featured
Residual inflammatory risk post STEMI: high prevalence despite LDL-C control and association with other secondary prevention targets
Medicine Residual risk Internal medicine Secondary prevention
May 29, 2026
News
A curated feed of new research, drugs, devices, guidelines, and policy — each summarized in plain language and linked to its original source. Featured items are the ones most worth your attention.
Note
Summaries are written by BlueRipple Health for general education and are not medical advice. Always read the linked source and discuss treatment decisions with your doctor.